Prognosis
AstraZeneca Covid Vaccine Technology Shows Promise for Cancer Shot
- Preclinical studies in mice found vaccine improved survival
- Human trials for the cancer shot are set to start this year
Vaccine research has advanced in the wake of the pandemic.
Photographer: SeongJoon Cho/BloombergThis article is for subscribers only.
Scientists behind the University of Oxford and AstraZeneca Plc Covid-19 shot are using the same technology to try to develop a therapeutic cancer vaccine, with promising results seen in animal studies.
Researchers from Oxford’s Jenner Institute and the Ludwig Institute for Cancer Research have designed a two-dose therapeutic cancer vaccine using technology involved in the Covid-19 inoculation, the scientists said in a study published in the Journal for ImmunoTherapy of Cancer Friday. The vaccine is set to enter human trials this year after studies in mice showed a reduction in tumor size and improved survival rate.